$BOTY
LINGERIE FIGHTING CHAMPIONSHIPS, INC.

2023 Q3 Form 10-Q Financial Statement

#000164033423001966 Filed on October 26, 2023

View on sec.gov

Income Statement

Concept 2023 Q3
Revenue $32.46K
YoY Change 27.81%
Cost Of Revenue $10.45K
YoY Change 7.73%
Gross Profit $22.01K
YoY Change 40.23%
Gross Profit Margin 67.8%
Selling, General & Admin $92.23K
YoY Change 25.09%
% of Gross Profit 419.11%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $92.23K
YoY Change 25.09%
Operating Profit -$70.22K
YoY Change 20.99%
Interest Expense $65.90K
YoY Change -13.64%
% of Operating Profit
Other Income/Expense, Net -$555.1K
YoY Change -9.48%
Pretax Income -$625.4K
YoY Change -6.84%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$625.4K
YoY Change -6.84%
Net Earnings / Revenue -1926.82%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 3.712B shares
Diluted Shares Outstanding 10.20B shares

Balance Sheet

Concept 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.150K
YoY Change -74.98%
Cash & Equivalents $3.153K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $3.153K
YoY Change -84.3%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets -$3.00
YoY Change -175.0%
TOTAL ASSETS
Total Short-Term Assets $3.153K
Total Long-Term Assets -$3.00
Total Assets $3.150K
YoY Change -84.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $652.7K
YoY Change 1303.05%
Accrued Expenses $608.5K
YoY Change 56.58%
Deferred Revenue
YoY Change
Short-Term Debt $1.021M
YoY Change 13.4%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.032M
YoY Change -12.43%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $5.032M
Total Long-Term Liabilities $0.00
Total Liabilities $5.032M
YoY Change -12.43%
SHAREHOLDERS EQUITY
Retained Earnings -$10.07M
YoY Change -5.45%
Common Stock $3.712M
YoY Change 4.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.029M
YoY Change
Total Liabilities & Shareholders Equity $3.153K
YoY Change -84.3%

Cashflow Statement

Concept 2023 Q3
OPERATING ACTIVITIES
Net Income -$625.4K
YoY Change -6.84%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$61.70K
YoY Change 371.35%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 61.44K
YoY Change
NET CHANGE
Cash From Operating Activities -61.70K
Cash From Investing Activities
Cash From Financing Activities 61.44K
Net Change In Cash -260.0
YoY Change -98.01%
FREE CASH FLOW
Cash From Operating Activities -$61.70K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
34800 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
51 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3711714036 shares
boty Related Party Balances And Transactionspolicytextblock
RelatedPartyBalancesAndTransactionspolicytextblock
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company follows FASB ASC 850, “<em>Related Party Disclosures</em>,” for the identification of related parties and disclosure of related party transaction. (See Note 9)</p>
CY2023Q3 boty Promissory Notes To Auctus Fund
PromissoryNotesToAuctusFund
340000 usd
CY2022Q4 boty Promissory Notes To Auctus Fund
PromissoryNotesToAuctusFund
340000 usd
CY2023Q3 us-gaap Notes Payable
NotesPayable
340000 usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
340000 usd
CY2021Q1 boty Warrants Price Per Share
WarrantsPricePerShare
0.002
CY2021Q1 us-gaap Debt Conversion Converted Instrument Warrants Or Options Issued1
DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
150000000 shares
CY2021Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
35000 usd
CY2021Q1 boty Warrants Derivative Amount
WarrantsDerivativeAmount
265000 usd
CY2021Q1 boty Debt Instrument Aggregate Discount
DebtInstrumentAggregateDiscount
300000 usd
CY2021Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
248077 usd
CY2021Q4 boty Warrants Price Per Share
WarrantsPricePerShare
0.0008
CY2021Q4 us-gaap Debt Conversion Converted Instrument Warrants Or Options Issued1
DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
50000000 shares
CY2021Q4 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
9000 usd
CY2021Q4 boty Warrants Derivative Amount
WarrantsDerivativeAmount
31000 usd
CY2021Q4 boty Debt Instrument Aggregate Discount
DebtInstrumentAggregateDiscount
40000 usd
CY2021Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
2740 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001407704
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
51 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
51 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
3711715 usd
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3711714036 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3711714036 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3711714036 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2023Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
2907433 usd
CY2023Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
2231144 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55498
dei Entity Registrant Name
EntityRegistrantName
LINGERIE FIGHTING CHAMPIONSHIPS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-8009362
dei Entity Address Address Line1
EntityAddressAddressLine1
6955 North Durango Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1115-129
dei Entity Address City Or Town
EntityAddressCityOrTown
Las Vegas
dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89149
dei City Area Code
CityAreaCode
702
dei Local Phone Number
LocalPhoneNumber
505-0743
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3711714036 shares
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3153 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10009 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
3153 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
10009 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
35572 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
37098 usd
CY2023Q3 boty Accounts Payable Related Parties
AccountsPayableRelatedParties
617128 usd
CY2022Q4 boty Accounts Payable Related Parties
AccountsPayableRelatedParties
542668 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
608473 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
442888 usd
CY2023Q3 boty Promissory Notes Payable Current
PromissoryNotesPayableCurrent
340000 usd
CY2022Q4 boty Promissory Notes Payable Current
PromissoryNotesPayableCurrent
340000 usd
CY2023Q3 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
24798 usd
CY2023Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
681176 usd
CY2022Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
584730 usd
CY2023Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2749485 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2967243 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5031834 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4914627 usd
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
3711715 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1327104 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1327104 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10067500 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9943437 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-5028681 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-4904618 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3153 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10009 usd
CY2023Q3 us-gaap Revenues
Revenues
32455 usd
CY2022Q3 us-gaap Revenues
Revenues
25393 usd
us-gaap Revenues
Revenues
88758 usd
us-gaap Revenues
Revenues
78831 usd
CY2023Q3 boty Cost Of Service
CostOfService
10449 usd
CY2022Q3 boty Cost Of Service
CostOfService
9700 usd
boty Cost Of Service
CostOfService
51252 usd
boty Cost Of Service
CostOfService
24657 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
22006 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
15693 usd
us-gaap Gross Profit
GrossProfit
37506 usd
us-gaap Gross Profit
GrossProfit
54174 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14549 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22728 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
41475 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
61240 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
47676 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
21000 usd
us-gaap Professional Fees
ProfessionalFees
72822 usd
us-gaap Professional Fees
ProfessionalFees
53000 usd
CY2023Q3 us-gaap Salaries And Wages
SalariesAndWages
30000 usd
CY2022Q3 us-gaap Salaries And Wages
SalariesAndWages
30000 usd
us-gaap Salaries And Wages
SalariesAndWages
90000 usd
us-gaap Salaries And Wages
SalariesAndWages
90000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
92225 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
73728 usd
us-gaap Operating Expenses
OperatingExpenses
204297 usd
us-gaap Operating Expenses
OperatingExpenses
204240 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-70219 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-58035 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-166791 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-150066 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
65902 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
76307 usd
us-gaap Interest Expense
InterestExpense
204141 usd
us-gaap Interest Expense
InterestExpense
257415 usd
CY2023Q3 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
-489230 usd
CY2022Q3 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
-536936 usd
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
246869 usd
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
1480510 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-555132 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-613243 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
42728 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1223095 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-625351 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-671278 usd
us-gaap Profit Loss
ProfitLoss
-124063 usd
us-gaap Profit Loss
ProfitLoss
1073029 usd
CY2023Q3 boty Earnings Per Shares Basic And Diluted1
EarningsPerSharesBasicAndDiluted1
-0.00
CY2022Q3 boty Earnings Per Shares Basic And Diluted1
EarningsPerSharesBasicAndDiluted1
-0.00
boty Earnings Per Shares Basic And Diluted1
EarningsPerSharesBasicAndDiluted1
-0.00
boty Earnings Per Shares Basic And Diluted1
EarningsPerSharesBasicAndDiluted1
0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q3 boty Basic And Diluted Weighted Average Shares Of Common Stock Outstanding
BasicAndDilutedWeightedAverageSharesOfCommonStockOutstanding
3711714036 shares
CY2022Q3 boty Basic And Diluted Weighted Average Shares Of Common Stock Outstanding
BasicAndDilutedWeightedAverageSharesOfCommonStockOutstanding
3535302536 shares
boty Basic And Diluted Weighted Average Shares Of Common Stock Outstanding
BasicAndDilutedWeightedAverageSharesOfCommonStockOutstanding
3711714036 shares
boty Basic And Diluted Weighted Average Shares Of Common Stock Outstanding
BasicAndDilutedWeightedAverageSharesOfCommonStockOutstanding
3535302536 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10200924610 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9821423487 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10200924610 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9821423487 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-4904618 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-72126 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-4976744 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
573414 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-4403330 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-625351 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-5028681 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-6798809 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
803986 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-5994823 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
940322 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-5054501 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-671278 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-5725779 usd
us-gaap Net Income Loss
NetIncomeLoss
-124063 usd
us-gaap Net Income Loss
NetIncomeLoss
1073029 usd
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-246869 usd
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-1480510 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
39112 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
100669 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
74460 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
57500 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1525 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
25671 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
165585 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
156746 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-93300 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-66895 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
86444 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
45000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
86444 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
45000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-6856 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-21895 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10009 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
34481 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3153 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12586 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
boty Debt Discount From Derivative Liabilities
DebtDiscountFromDerivativeLiabilities
29111 usd
boty Debt Discount From Derivative Liabilities
DebtDiscountFromDerivativeLiabilities
52000 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 1 – ORGANIZATION AND NATURE OF BUSINESS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Lingerie Fighting Championships, Inc. (the “Company”) is a Nevada corporation incorporated on November 29, 2006 under the name Sparking Events, Inc. The Company’s corporate name was changed to Xodtec Group USA, Inc. in June 2009, Xodtec LED, Inc. in May 2010, Cala Energy Corp. in September 2013 and Lingerie Fighting Championships, Inc. on April 1, 2015.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company focuses on developing, producing, promoting, and distributing entertainment through live entertainment events, digital home videos, broadcast television networks, video on demand, and digital media channels in the United States. It offers wrestling and mixed martial arts fights featuring women under the LFC brand name.</p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company continually evaluates its estimates and judgments. The Company bases its estimates and judgments on historical experience and other factors that it believes to be reasonable under the circumstances. Materially different results can occur as circumstances change and additional information becomes known, even for estimates and judgments that are not deemed critical.</p>
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3153 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10009 usd
us-gaap Revenues
Revenues
88758 usd
us-gaap Revenues
Revenues
78831 usd
us-gaap Cost Of Revenue
CostOfRevenue
51252 usd
us-gaap Cost Of Revenue
CostOfRevenue
24657 usd
us-gaap Gross Profit
GrossProfit
37506 usd
us-gaap Gross Profit
GrossProfit
54174 usd
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
6489210574 shares
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
6286120951 shares
CY2023Q3 us-gaap Derivative Assets
DerivativeAssets
0 usd
CY2023Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
2749485 usd
CY2022Q4 us-gaap Derivative Assets
DerivativeAssets
0 usd
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
2967243 usd
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
51 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
51 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3711714036 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5556666666 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.0001
CY2022 boty Number Of Shares Granted
NumberOfSharesGranted
282080000 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.0005
CY2022 boty Exercised
Exercised
-201613143 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.0001
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5637133523 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.0001
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5637133523 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.0001
boty Expected Term
ExpectedTerm
P2Y2M1D
boty Expected Term
ExpectedTerm
P3Y1M6D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
979677 usd
CY2023Q3 boty Closing Market Price
ClosingMarketPrice
0.0003
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
5637133523 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1642147 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1683773 shares
boty Schedule Of Promissory Notes Payable
ScheduleOfPromissoryNotesPayable
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Promissory Notes to Auctus Fund</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">340,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">340,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total Promissory Notes</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">340,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">340,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
us-gaap Interest And Debt Expense
InterestAndDebtExpense
126093 usd
us-gaap Interest And Debt Expense
InterestAndDebtExpense
117254 usd
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
2967243 usd
us-gaap Additional Liability Long Duration Insurance Increase Decrease From Discount Rate Change
AdditionalLiabilityLongDurationInsuranceIncreaseDecreaseFromDiscountRateChange
29111 usd
boty Gain On Change In Fair Value Of The Derivative
GainOnChangeInFairValueOfTheDerivative
-246869 usd
CY2023Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
2749485 usd
boty Day One Loss Due To Derivative Liabilities On Convertible Notes And Warrant
DayOneLossDueToDerivativeLiabilitiesOnConvertibleNotesAndWarrant
0 usd
boty Day One Loss Due To Derivative Liabilities On Convertible Notes And Warrant
DayOneLossDueToDerivativeLiabilitiesOnConvertibleNotesAndWarrant
72101 usd
boty Gain Loss On Change In Fair Value Of Derivative Liabilities On Convertible Notes And Warrants
GainLossOnChangeInFairValueOfDerivativeLiabilitiesOnConvertibleNotesAndWarrants
-246869 usd
boty Gain Loss On Change In Fair Value Of Derivative Liabilities On Convertible Notes And Warrants
GainLossOnChangeInFairValueOfDerivativeLiabilitiesOnConvertibleNotesAndWarrants
-1552611 usd
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-246869 usd
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-1480510 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P0Y4M2D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P0Y7M13D
CY2023Q3 boty Amount Due To Related Parties
AmountDueToRelatedParties
617128 usd
CY2022Q4 boty Amount Due To Related Parties
AmountDueToRelatedParties
542668 usd

Files In Submission

Name View Source Status
boty-20230930_pre.xml Edgar Link unprocessable
boty-20230930_lab.xml Edgar Link unprocessable
0001640334-23-001966-index-headers.html Edgar Link pending
0001640334-23-001966-index.html Edgar Link pending
0001640334-23-001966.txt Edgar Link pending
0001640334-23-001966-xbrl.zip Edgar Link pending
boty-20230930.xsd Edgar Link pending
boty_10q.htm Edgar Link pending
boty_ex311.htm Edgar Link pending
boty_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
boty-20230930_cal.xml Edgar Link unprocessable
boty-20230930_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
boty_10q_htm.xml Edgar Link completed
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending